Voyager Therapeutics Inc (VYGR)
SG&A Expense Growth
-9.02%
Quarterly · Period ending:
VYGR SG&A Expense Growth
Latest reported-9.02%period ending
Latest reported-9.02%period ending
VYGR Quarterly SG&A Growth (QoQ) (0.00% → -9.02%)
Latest values, visible window
High-resolution chart · PNG
VYGR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -9.0183% | |
| -11.3246% | |
| 15.1118% | |
| -22.8871% | |
| 8.8693% | |
| 7.1826% | |
| 10.1126% | |
| -19.535% | |
| 17.9389% | |
| -15.9637% | |
| 24.0252% | |
| -0.4341% | |
| -8.1303% | |
| 6.6887% | |
| 15.8068% | |
| -3.2442% | |
| -1.397% | |
| -8.2864% | |
| -4.1657% | |
| -16.5086% | |
| 7.1121% | |
| 17.8235% | |
| -0.0846% | |
| 0.4612% | |
| -19.273% | |
| 3.1847% | |
| 16.8734% | |
| 1.6943% | |
| -13.842% | |
| 17.0079% | |
| 24.9054% | |
| -43.8106% | |
| 63.7705% | |
| 33.8427% | |
| 8.5795% | |
| 9.4331% | |
| -8.0993% | |
| 41.1663% | |
| 3.2938% | |
| 18.0799% | |
| -19.9439% | |
| 12.9237% | |
| 27.5556% | |
| 3.2972% | |
| 27.3791% | |
| 22.4609% | |
| 22.1957% | |
| 11.9323% | |
| -27.6883% | |
| 0% |